Korean Cancer Study Group
9 clinical trials · Sponsor
◉ Watch Korean Cancer Study Group
| Record | Firm | Date |
|---|---|---|
| A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP) (NCT04751955) | Korean Cancer Study Group | 2022-01-01 |
| Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer (NCT05079503) | Korean Cancer Study Group | 2021-12-15 |
| Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients (NCT04753203) | Korean Cancer Study Group | 2021-02-28 |
| Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer (NCT03698383) | Korean Cancer Study Group | 2019-12-03 |
| A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers (NCT04761744) | Korean Cancer Study Group | 2019-06-14 |
Track Korean Cancer Study Group automatically
Every clearance here is in the API, with alerts when new ones post.